ORAL CARE METHODS AND COMPOSITIONS UTILIZING CHITOSAN-DERIVATIVE COMPOUNDS
Described herein is a method of reducing bacteria in the mouth of a subject, the method comprising contacting (e.g., rinsing) the mouth with an effective amount of a composition comprising a soluble derivatized chitosan, thereby reducing bacteria in the mouth of the subject.
1 . A method of reducing bacteria in the mouth of a subject, the method comprising:
contacting the mouth with an effective amount of a composition comprising a soluble derivatized chitosan, wherein the derivatized chitosan comprises a chitosan of the following formula (I):
wherein:
n is an integer between 20 and 6000; and
each R 1 is independently selected for each occurrence from hydrogen, acetyl, and a group of formula (II):
wherein at least 25% of R 1 substituents are H, at least 1% of R 1 substituents are acetyl, and at least 2% of R 1 substituents are a group of formula (II),
thereby reducing bacteria in the mouth of the subject.
2 . The method of claim 1 , wherein the amount of the bacteria in the mouth of the subject is reduced by at least 50%, compared to the amount of the bacteria that has not been contacted with the composition.
3 . The method of claim 1 , wherein the subject rinses the mouth with at least 2 ml of the composition comprising the composition.
4 . The method of claim 1 , wherein the subject rinses the mouth with the composition for a period of at least 15 seconds.
5 . The method of claim 1 , wherein the composition is not ingested by the subject.
6 . The method of claim 1 , wherein the subject rinses the mouth with the composition at least once per day.
7 . (canceled)
8 . The method of claim 1 , wherein the subject rinses the mouth with at least 10 ml of the composition twice per day.
9 . The method of claim 1 , wherein the concentration of the soluble derivatized chitosan is at least 5 ppm (e.g., from about 100-250 ppm).
10 . (canceled)
11 . The method of claim 1 , wherein the subject has one or more oral disease or condition.
12 . The method of claim 11 , wherein the oral disease or condition is dental plaque, gingivitis, dental caries, or halitosis.
13 . The method of claim 1 , wherein the subject has dental plaque, swollen gums, mouth sores, bright-red or purple gums, shiny gums, swollen gums that emit pus, severe oral odor, gums that are painless except when pressure is applied, gums that bleed easily even with gentle brushing and especially when flossing, or gums that itch with varying degrees of severity.
14 . The method of claim 1 , wherein the subject is infected with Streptococcus mutans, Streptococcus sanguis, Treponema denticola, Porphyromonas gingivalis, Aggregatibacter actinomycetemcomitans, Fusospirochetes, Veillonella , and some forms of pathogenic Lactobacilli, Actinomyces viscosus , or Nocardia spp.
15 . The method of claim 1 , further comprising the step of administering an antibiotic to a subject.
16 . The method of claim 1 , further comprising the step of physically removing superficial layers of bacteria and related debris from the mouth through use of mechanical or ultrasonic debridement.
17 .- 87 . (canceled)
88 . The method of claim 1 , wherein the composition further comprises an additional agent, wherein the additional agent is xylitol.
89 . (canceled)
90 . The method of claim 1 , wherein the composition is substantially free of a chitosan polymer wherein one or more of the nitrogen-containing groups of the glucosamine monomer is substituted with a polymerized amino acid.
91 . (canceled)
92 . A method of disrupting a biofilm, or preventing the formation of a biofilm in the mouth of a subject, the method comprising:
contacting the mouth with an effective amount of a composition comprising a soluble derivatized chitosan, wherein the derivatized chitosan comprises a chitosan of the following formula (I):
wherein:
n is an integer between 20 and 6000; and
each R 1 is independently selected for each occurrence from hydrogen, acetyl, and a group of formula (II):
wherein at least 25% of R 1 substituents are H, at least 1% of R 1 substituents are acetyl, and at least 2% of R 1 substituents are a group of formula (II),
thereby disrupting the biofilm in the mouth of the subject.
93 .- 97 . (canceled)
98 . A medical device constructed to fit into the mouth of a subject, wherein the surface of the medical device is coated with a soluble derivatized chitosan, wherein the derivatized chitosan comprises a chitosan of the following formula (I):
wherein:
n is an integer between 20 and 6000; and
each R 1 is independently selected for each occurrence from hydrogen, acetyl, and a group of formula (II):
wherein at least 25% of R 1 substituents are H, at least 1% of R 1 substituents are acetyl, and at least 2% of R 1 substituents are a group of formula (II).
99 .- 100 . (canceled)